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Available online 4 October 2013Abstract Reactive oxygen species (ROS) are involved in various aspects of cancer cell biology, yet their role in cancer stem cells
(CSCs) has been poorly understood. In particular, it still remains unclear whether and how ROS control the self-renewal/
differentiation process and the tumor-initiating capacity of CSCs. Here we show that ROS-mediated activation of p38 MAPK plays a
pivotal role in the control of differentiation and tumor-initiating capacity of glioma-initiating cells (GICs) derived from human
glioblastomas. Mechanistically, ROS triggered p38-dependent Bmi1 protein degradation and FoxO3 activation in GICs, which were
shown to be responsible for the loss of their self-renewal capacity and differentiation, respectively. Thus, the results suggest that
Bmi1 and FoxO3 govern distinct phases of transition from undifferentiated to fully differentiated cells. Furthermore, we also
demonstrate in this study that oxidative stress deprives GICs of their tumor-initiating capacity through the activation of the ROS–p38
axis. As such, this is the first study to the best of our knowledge to delineate how ROS control self-renewal/differentiation and the
tumor-initiating capacity of stem-like cancer cells. This study also suggests that targeting of the ROS–p38 axis could be a novel
approach in the development of therapeutic strategies against gliomas, represented by glioblastoma.
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Glioblastoma is one of the deadliest among human cancers
with highly dismal prognosis (Stupp et al., 2005; Tabatabai
and Weller, 2011). Even with seemingly successful initial
treatment, recurrence is inevitable and almost always fatal
in themajority of glioblastoma cases, which implies that the
control of recurrence is key to realizing long-term survival
of glioblastoma patients (Cheng et al., 2010; Neman and
Jandial, 2010). A growing body of evidence now suggests
that glioblastomas contain a small subpopulation of imma-
ture, undifferentiated tumor cells with tumor-initiating
capacity, which is lost once they undergo differentiation
(Binello and Germano, 2011; Cheng et al., 2010; Tabatabai
and Weller, 2011). Such cells are called glioma stem cells
(or alternatively, stem-like glioma cells, glioma-initiating
cells [GICs], glioma-propagating cells), and due to their
inherent therapy resistance, are now deemed a possible
culprit of glioblastoma recurrence (Binda et al., 2012).
Elucidation of the molecular mechanisms underlying the
maintenance of the immature, stem cell state of glioma
stem cells as well as the process of their differentiation,
therefore, is expected to lead to the identification of novel
targets of therapeutic intervention to prevent recurrence
and thus could contribute to better clinical management of
this devastating disease.
Currently, with the dramatic expansion of research in
the field of glioma stem cells, an increasing number of
molecules/pathways involved in their maintenance and
differentiation, e.g., bone morphogenetic proteins and trans-
forming growth factor β, are being identified (Binello and
Germano, 2011). However, the role of reactive oxygen species
(ROS) in cancer stem cells, including glioma stem cells, has
been poorly characterized with only limited information
published to date (Kobayashi and Suda, 2012), in contrast to
their well-documented, pleiotropic roles in cancer cell biology
in general (Pan et al., 2009). In particular, although previous
studies implicated ROS in the radioresistance of breast cancer
stem cells (Diehn et al., 2009; Phillips et al., 2006), the role of
ROS in the control of stem cell state/differentiation of cancer
stem cells remains largely undetermined (Shi et al., 2012).
Here in this study, to address this important, unanswered
question, we investigated the role of ROS in GICs having
stem-like properties (stem-like GICs). We found that p38
MAPK activated by ROS mediates the loss of self-renewal and
differentiation of stem-like GICs induced by oxidative stress.
Intriguingly, we also found that Bmi1 and FoxO3 under the
control of this ROS–p38 axis play critical roles at distinct
phases of transition from the undifferentiated to differen-
tiated state. The pivotal role of the ROS–p38 axis in the
control of stem-like GICs and their tumor-initiating capacity
demonstrated in this study suggests that the axis may be a
novel node for therapeutic targeting of stem-like GICs.
Materials and methods
Reagents and antibodies
Hydrogen peroxide solution (H2O2, #216763), N-acetyl-
L-cysteine (NAC, #A9165), L-buthionine-sulfoximine (BSO,
#B2515), 2′,7′-dichlorofluorescein diacetate (DCF-DA,#35845), cycloheximide solution (#C4859) and SB203580
(#S8307) were purchased from Sigma-Aldrich. MG132
(#BML-PI102) and SL327 (#EI-365) were from Enzo Life
Sciences. LY294002 (#440202) was purchased from Calbiochem.
Hoechst33342 (#H3570) was from Invitrogen.
The following antibodies were used: Anti-Nestin (#AB5922),
Anti-Neurofilament H (#MAB5446) and Anti-Bmi-1 (#05-637)
from Millipore; SOX2 (#MAB2018), GFAP (#AF2594), and
βIII-tubulin (#MAB1195) from R&D Systems; and phospho-Akt
(#4058), Akt (#9272), phospho-ATF-2 (#9221), ATF-2 (#9222),
phospho-Erk1/2 (#9106), Erk1/2 (#4695), FoxO3a (#2497),
phospho-p38 (#4511), p38 (#9212), p21 (#2947) and PARP
(#9542) from Cell Signaling Technology. Anti-α-tubulin (#CP06)
was from Oncogene. Anti-Musashi-1 (#ab21628) was from
Abcam. Anti-β-actin (#A1978) was from Sigma-Aldrich. HRP-
conjugated secondary antibodies for immunoblotting were
purchased from Jackson ImmunoResearch Laboratories. Alexa
488- and 568-conjugated secondary antibodies for immunocy-
tochemistry were from Invitrogen.Culture of GICs and sphere formation assay
Patient-derived GICs used in this study were directly
established from glioblastoma tissues in accordance with a
protocol approved by the Institutional Review Boards of
Yamagata University School of Medicine and National Cancer
Center (GS-Y03, GS-NCC01) (Matsuda et al., 2012; Sunayama
et al., 2010a, 2010b, 2011) or were kindly provided by Drs.
Tomoki Todo and Nobuhito Saito at the University of Tokyo
(TGS01) (Ikushima et al., 2009; Matsuda et al., 2012; Sato
et al., 2011). The patient-derived GICs weremaintained under
the monolayer stem cell culture condition reported previous-
ly, and the determination of the cell number and viability was
also carried out essentially as described (Matsuda et al., 2012;
Sato et al., 2012).
Unless otherwise indicated, sphere formation assay was
done essentially as previously described (Matsuda et al.,
2012; Sato et al., 2012). Monolayer-cultured GICs were,
after being detached from the dish and dissociated into
single cells mechanically (i.e., by pipetting), suspended in
the stem cell culture medium at a density of 5 × 103 cells/ml.
Then, 200 μl of the cell suspension (1 × 103 cells) was
transferred to each well of a non-coated 96-well plate.
The number of primary spheres was counted after 3
(TGS01) or 6 (GS-Y03 and GS-NCC01) days. For secondary
sphere formation, primary spheres formed by cells
seeded onto non-coated 35-mm dishes at a density of
5 × 103 cells/ml in the stem cell culture medium were
collected 3 days after seeding, dissociated, and 200 μl of
the cell suspension (5 × 103 cells/ml in the stem cell
culture medium) was transferred to each well of a
non-coated 96-well plate. Secondary spheres were simi-
larly counted after 3 (TGS01) or 6 (GS-Y03 and GS-NCC01)
days. Tertiary sphere formation assay was performed
essentially in the same manner as the primary and
secondary sphere formation assays. Where indicated, the
sphere formation capacity of GICs was also assessed by
limiting dilution. Cells were diluted in the stem cell
culture medium and seeded so that there will be a single
cell in each well of non-coated 96-well plates. After
seeding, wells containing a single cell were marked, and
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the total number of marked wells was determined 7 days
after seeding.
Detection and measurement of intracellular ROS
Cells were incubated with the stem cell culture medium
containing 10 μM 2′,7′-dichlorofluorescein diacetate (DCF-DA)
for 10 min at 37 °C, washed twice with phosphate-buffered
saline, and fixed with 4% (w/v) paraformaldehyde for 5 min at
room temperature. Care was taken to shield light during
these procedures. The cells were then subjected either to
fluorescence microscopy using an epifluorescence microscope
(CKX41; Olympus) equipped with a CCD camera system
(DP-30BW; Olympus) or to flow cytometric analysis for
quantification of the intensity of DCF fluorescence using a
BD FACSCalibur flow cytometer (Becton Dickinson). For flow
cytometric analysis, at least 5 × 105 cells were evaluated
and gated using side and forward scatters to identify live
cell populations.
Gene silencing by siRNA
Monolayer-cultured GICs seeded at a density of 2 × 105 cells/ml
in the stem cell culture medium on collagen-coated dishes
were transfected with siRNAs using Lipofectamine RNAiMAX
Reagent (Invitrogen). siRNAs against MAPK14 (p38α) (p38-#1
[HSS102352] and p38-#2 [HSS102353]), siRNAs against Bmi1
(Bmi1-#1 [HSS101038] and Bmi1-#2 [HSS101039]), and a non-
targeting control siRNA (Stealth RNAi™ siRNA Negative Control
Duplexes [Medium GC Duplexes #2, 12935112]) were pur-
chased from Invitrogen.
Immunoblot analysis
Cells were washed with phosphate-buffered saline and then
lysed in the lysis buffer (10 mM Tris–HCl, pH 7.4, 0.1% (w/v)
SDS, 1% (w/v) sodium deoxycholate, 0.15 M NaCl, 1 mM EDTA,
and 1% (v/v) protease inhibitor cocktail set III; Merck). After
determination of the protein concentrations by using a BCA
protein assay kit (Thermo Fisher Scientific), cell lysates
containing equal amounts of protein were separated by
SDS-PAGE and electrically transferred to polyvinylidene
difluoride membranes. The membrane was probed with
a primary antibody and then with an appropriate HRP-
conjugated secondary antibody. Blots were visualized with
Immobilon Western HRP Substrate (Millipore) or ECL Western
Blotting Detection Reagent (GE Healthcare).
Subcellular fractionation
Cells were homogenized in hypotonic buffer (10 mM Tris–HCl,
pH 7.8, 150 mM NaCl, and 1 mM EDTA) containing 0.1% (w/v)
Triton X-100. The lysates were centrifuged at 3000 rpm for
10 min at 4 °C and separated into pellet and supernatant
fractions. The pellet was re-suspended in hypotonic buffer
containing 0.1% (v/v) Triton X-100 and re-centrifuged. The
pellet was used as the nuclear fraction. The supernatant
fraction was re-centrifuged at 15,000 rpm for 20 min at 4 °C
and used as the cytoplasmic fraction.Immunofluorescence
Cells were plated onto collagen-coated coverslips (Iwaki)
in the stem cell culture medium and fixed with 4% (w/v)
paraformaldehyde for 30 min at room temperature. The
fixed cells were permeabilized in 0.5% (w/v) Triton X-100 for
5 min, washed twice with PBS, and incubated in a blocking
solution (phosphate-buffered saline containing 2% (w/v)
bovine serum albumin and 2% (v/v) fetal bovine serum) for
30 min. The cells were incubated in the blocking solution
with the primary antibodies overnight at 4 °C and then
with the secondary antibodies for 1 h at room temperature.
Immune complexes were observed under an epifluorescence
microscope (CKX41; Olympus) equipped with a CCD camera
system (DP-30BW; Olympus).
RT-PCR analysis
Total RNA was extracted with TRIzol (Invitrogen). Total RNA
was reverse-transcribed into cDNA using M-MLV (Invitrogen)
according to the manufacturer's instruction.
RT-PCR analysis was performed with the following primers.
bmi1 (F; 5′-GGAGACCAGCCAGTATTGTCCTATTTG-3′, R; 5′-CA
TTGCTGCTGGGCATCGTAAG-3′)
gapdh (F; 5′-TCCTGTTCGACAGTCAGCCGCATCTT-3′, R; 5′-GAC
CAGGCGCCCAATACGACCAA-3′)
Mouse xenograft analysis
For intracranial xenografts, monolayer-cultured GS-Y03 cells
(1 × 104) in 10 μl PBS were injected stereotactically into the
right corpus striatum (2.5 mm anterior and 2.5 mm lateral
to the bregma, and 3.0 mm deep) of 5-week-old male BALB/
cAJcl-nu/nu mice (CLEA Japan). All animal experiments were
performed under the approval of the Animal Research Commit-
tee of Yamagata University.
Statistical analysis
Quantitative data are expressed as means ± SD, and differ-
ences were compared using two-tailed Student's t-test.
Mouse survival was evaluated by the Kaplan–Meier method
and analyzed by using the log-rank test. P values less than
0.05 were considered statistically significant.
Results
Hydrogen peroxide inhibits self-renewal and induces
differentiation of GICs via increase in
intracellular ROS
The results of pilot experiments in our recent study indicated
that hydrogen peroxide treatment induces differentiation of a
patient-derived GIC, GS-NCC01 (previously designated SJ28P3),
in a FoxO3-dependent manner (Sunayama et al., 2011), which
suggested the possibility that intracellular ROS elevation as
a result of oxidative stress caused by hydrogen peroxide
may play a role in the differentiation of the GIC. To test this
idea and whether the mechanism is shared by other GICs, we
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three patient-derived GICs (including GS-NCC01) established
in three different institutions (Fig. 1). When the GICs were
treated with hydrogen peroxide at different concentrations and
the intracellular ROS levels were measured by DCF-DA staining,
we found that the extent of increase in the intracellular ROS
levels varied depending on the GIC examined. Nevertheless,
when the cells were treated with hydrogen peroxide at 100 μM
or higher concentrations, we could consistently detect signif-
icant elevation of the intracellular ROS levels in all three GICs
(Fig. 1; Figs. S2 and S12). In the following experiments,
therefore, the experiments were conducted using 100 μM
hydrogen peroxide unless otherwise indicated. To determine
whether hydrogen peroxide induces differentiation of the
GICs, and if so, through elevation of the intracellular ROS
levels, we treated the GICs (GS-NCC01, GS-Y03, and TGS01)
with 100 μM hydrogen peroxide in the presence and absence
of an antioxidant N-acetylcysteine (NAC), which acts as a free
radical scavenger by promoting intracellular biosynthesis of
glutathione (GSH) (Kelly, 1998). Treatment of GICs with
100 μM hydrogen peroxide resulted in increased intracellular
ROS as early as 30 min after treatment, and the intracellular
ROS level remained above the baseline for 48 h (Fig. S1).
Under this treatment condition, hydrogen peroxide reduced
sphere formation by GICs (Figs. 1D and E; Fig. S2C) without
causing substantial reduction in their viability (Fig. S3), and
also reduced their stem cell marker expression (Nestin, Sox2,
Bmi1) while inducing expression of differentiation markers
such as GFAP, neurofilament H (NF-H) (Fig. 1B) and
βIII-tubulin (Fig. 1C; Fig. S2B), in all three GICs. Importantly,
NAC, which completely inhibited hydrogen peroxide-induced
elevation of the intracellular ROS levels (Fig. 1A; Fig. S2A),
almost totally canceled the effect of hydrogen peroxide on the
sphere forming capacity (Fig. 1D; Fig. S2C) and stem cell/
differentiation marker expression (Figs. 1B and C; Fig. S2B) of
the GICs. These results indicate that hydrogen peroxide
inhibits self-renewal and induces differentiation of stem-like
GICs by increasing intracellular ROS.Hydrogen peroxide inhibits self-renewal and induces
differentiation of GICs via ROS-dependent
activation of p38 MAPK
Next, to identify the signaling pathway(s) involved in ROS-
mediated differentiation of GICs, we first searched for
candidate signaling pathways that could be activated
or inhibited in a ROS-dependent manner. As we reported
previously (Sunayama et al., 2011), the activity of theFigure 1 Hydrogen peroxide treatment inhibits self-renewal and
(A) GS-Y03 cells cultured in the presence or absence of NAC (10 mM
for another 30 min. The cells were then stained with DCF-DA and su
Hoechst 33342 (Hoechst) (left panels; identical visual fields are sh
cytometry (right panel), to detect intracellular ROS. Scale bars, 100
of NAC (10 mM) for 30 min were further treated with or without
immunoblot analysis for the expression of stem cell and differentiatio
to immunofluorescence analysis for GFAP and βIII-tubulin expression
Scale bars, 100 μm. (D) GS-Y03 cells treated as in (B) were subjected
formed. The data represent means ± SD from 3 independent experim
sphere forming capacity by limiting dilution. The graph shows the perc
from 3 independent experiments.MAPK pathway as assessed by phosphorylated ERK remained
unchanged when cells were treated with hydrogen peroxide in
the presence and absence of NAC. Of note, in contrast to our
previous report (Sunayama et al., 2011), a modest increase in
phosphorylated Akt was observed upon hydrogen peroxide
treatment, most likely due to the higher concentration
(100 μM vs. 10 μM) of hydrogen peroxide used in this study
to achieve a significant increase in the intracellular ROS levels
in all three GICs (Fig. 2A; Fig. S4A). Quite intriguingly, we
noticed in the course of our experiments that phosphorylation
of p38 MAPK was commonly increased in all the GICs
examined, apparently in a ROS-dependent manner as
evidenced by its inhibition by NAC (Fig. 2A; Fig. S4A). Then,
to determine whether p38 is indeed involved in hydrogen
peroxide-induced differentiation and loss of self-renewal, we
investigated the effect of p38 knockdown on the stem-like
properties of the GICs, using two different siRNAs against p38.
Both siRNAs effectively knocked down p38 and prevented
hydrogen peroxide-induced activation of p38 (Fig. 2C; Fig.
S5A). Under this experimental condition, the siRNAs against
p38 blocked hydrogen peroxide-induced differentiation
(Fig. 2C; Fig. S5A) and loss of self-renewal (Figs. 2C and E;
Figs. S5A and B). The results of the knockdown study were
further corroborated by the use of SB203580, a pharmacolog-
ical inhibitor of p38. SB203580 prevented hydrogen
peroxide-induced expression of differentiation markers
(Fig. 2D; Fig. S6B), suggesting that p38 is required for
hydrogen peroxide-induced differentiation of GICs. Similarly,
SB203580 effectively blocked hydrogen peroxide-induced
reduction in stem cell marker expression (Fig. 2D; Fig. S6B)
and sphere formation (Fig. S4B) of GICs, demonstrating that
p38 is responsible for the loss of self-renewal induced by
hydrogen peroxide. Of note, SB203580 did not affect the
intracellular ROS levels (Fig. 2B; Fig. S6A), consistent with the
idea that p38 functions downstream of ROS in GICs. Collec-
tively, these data indicate that ROS-dependent activation of
p38 is essential for both loss of self-renewal and differenti-
ation of GICs induced by hydrogen peroxide.
Downregulation of Bmi1 expression precedes
alteration of stem cell/differentiation marker
expression induced by hydrogen peroxide and
is sufficient to cause loss of self-renewal but
not differentiation of GICs
In an attempt to obtain clues to further delineate the
mechanism underlying hydrogen peroxide-induced differ-
entiation of GICs, we conducted a time course analysis ofinduces differentiation of GICs via increase in intracellular ROS.
) for 30 min were further treated with or without H2O2 (100 μM)
bjected to fluorescence microscopy after nuclear staining with
own for each pair of DCF-DA and Hoechst staining) or to flow
μm. (B) The indicated GICs cultured in the presence or absence
H2O2 (100 μM) for 6 days. The cells were then subjected to
n markers. (C) GS-Y03 cells were treated as in (B) and subjected
(green). Nuclei were counter-stained with Hoechst 33342 (blue).
to sphere formation assay to determine the number of spheres
ents. (E) GS-Y03 cells treated as in (B) were assessed for their
entage of wells with a sphere, and the data represent means ± SD
Figure 2 Hydrogen peroxide inhibits self-renewal and induces differentiation of GICs via intracellular ROS-dependent activation of
p38 MAPK. (A) GS-Y03 cells cultured in the presence or absence of NAC (10 mM) for 30 min were further treated with or without H2O2
(100 μM) for 1 h. The cells were then subjected to immunoblot analysis of the indicated proteins. (B) GS-Y03 cells cultured in the
presence or absence of SB203580 (SB) for 30 min were further treated with or without H2O2 (100 μM) for another 30 min. Then the
cells were stained with DCF-DA and analyzed by flow cytometry. (C) GS-Y03 cells were transfected with the indicated siRNAs. After
10 h, the transfected cells were treated with or without H2O2 (100 μM) for 6 days and then subjected to immunoblot analysis.
(D) GS-Y03 cells cultured in the presence or absence of SB203580 (SB) were further treated with or without H2O2 (100 μM) for 6 days.
The cells were then subjected to immunoblot analysis. (E) GS-Y03 cells were treated as in (C) and then subjected to sphere formation
assays. The data represent means ± SD from 3 independent experiments.
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Figure 3 Downregulation of Bmi1 expression precedes alteration of stem cell/differentiation marker expression induced by
hydrogen peroxide and is sufficient to cause loss of self-renewal but not differentiation of GICs. (A, B) GS-Y03 cells cultured in the
absence (Control) or presence of H2O2 (100 μM) for the indicated time periods were subjected to immunoblot analysis for the
expression of stem cell (A) and differentiation (B) markers. (C–E) GS-Y03 cells transfected with the indicated siRNAs were, 6 days
after transfection, subjected to immunoblot analyses (C and E) or to sphere formation assays (D). In (D), the data represent means ± SD
from 3 independent experiments.
125ROS-p38 regulation of glioma-initiating cellsstem cell/differentiation marker expression. Under the
experimental condition of this study, decreased expression
of Bmi1, a stem cell marker, was already apparent at 1 day
after hydrogen peroxide treatment, whereas the expression
of the other stem cell markers (Sox2, Musashi, Nestin) began
to decline between 1 and 3 days after hydrogen peroxide
treatment (Fig. 3A; Fig. S7A). The expression of differenti-
ation markers became detectable later than 3 days and
was invariably robust at 6 days after hydrogen peroxide
treatment (Fig. 3B; Fig. S7B). Thus, the results of the time
course analysis suggested that the process of hydrogen
peroxide-induced differentiation of the GICs is preceded by
the downregulation of Bmi1 followed by other stem cell
markers, and then by the upregulation of differentiation
markers. Given a previous report showing that Bmi1 expres-
sion is required for the maintenance of the undifferentiated
state of GICs (Abdouh et al., 2009), we hypothesized that the
initial downregulation of Bmi1 may serve as a cue for the
subsequent downregulation of the other stem cell markers
and upregulation of the differentiation markers. To test this
possibility, we investigated the impact of Bmi1 knockdown
on stem cell/differentiation marker expression as well as on
the sphere formation capacity of the GICs. When Bmi1 was
knocked down using two different siRNAs, upregulation of p21,
a Bmi1 target, was confirmed along with reduced expression
of Bmi1, implying that both siRNAs knocked down Bmi1
effectively in the GICs (Fig. 3C; Fig. S7C). Then, under this
experimental condition, the GICs with or without Bmi1knockdown were subjected to sphere formation assay or to
analysis of stem cell/differentiation marker expression. As
expected, Bmi1 knockdown caused substantial reduction in
sphere formation (Fig. 3D; Fig. S7D) and stem cell marker
expression (Fig. 3E; Fig. S7E). However, unexpectedly, we
failed to detect the expression of differentiation markers even
at 6 days after Bmi1 knockdown (Fig. 3E; Fig. S7E). Thus, the
data suggested that the downregulation of Bmi1 caused by
hydrogen peroxidemay be sufficient for the loss of self-renewal
(i.e., loss of stem cell marker expression and sphere formation
capacity) but not for the induction of differentiation of GICs.Hydrogen peroxide promotes Bmi1
protein degradation in a p38
MAPK-dependent manner
We have demonstrated earlier in this study that the ROS–p38
axis mediates hydrogen peroxide-induced loss of self-renewal
and differentiation of GICs. We next wished to determine,
therefore, the mechanistic link between p38 activation and
Bmi1 downregulation in GICs. Notably, while conducting
detailed time course analysis of Bmi1 mRNA and protein
expression, we found that the mechanism of reduced Bmi1
protein expression is primarily post-transcriptional: where-
as reduced protein expression of Bmi1 was apparent as early
as 8 h after hydrogen peroxide treatment (Fig. 4A), the
mRNA expression of Bmi1 remained unchanged even at 24 h
Figure 4 Hydrogen peroxide promotes Bmi1 protein degradation in a p38 MAPK-dependent manner. (A, B) The indicated GICs
treated with or without H2O2 (100 μM) for the indicated periods were subjected to immunoblot (A) and RT-PCR (B) analyses for
protein and mRNA expression of Bmi1, respectively. (C, D) GS-Y03 cells treated with or without cycloheximide (CHX, 50 μg/ml) (C) or
MG132 (20 μM) (D) for the indicated periods were subjected to immunoblot analysis for Bmi1 protein expression. (E, F) GS-Y03 cells
treated with the indicated combinations of cycloheximide (CHX, 50 μg/ml), H2O2 (100 μM), and SB203580 (SB, 10 μM) for the
indicated periods were subjected to immunoblot analysis for Bmi1 protein expression. In (F), SB203580 was added to the culture
medium 30 min before cycloheximide and H2O2.
126 A. Sato et al.(Fig. 4B; Fig. S8). To determine whether Bmi1 is regulated at
the post-transcriptional level through proteasomal degradation
as recently reported (Kim et al., 2011), we examined the time
course of Bmi1 protein expression in the absence of de novo
protein synthesis using cycloheximide, and also examined the
effect of MG132, a proteasomal inhibitor, on Bmi1 protein
expression. The results suggested that the Bmi1 protein is
rapidly degraded (Fig. 4C; Fig. S9A) in the GICs and that
proteasome activity may be involved in Bmi1 protein degrada-
tion (Fig. 4D; Fig. S9B). We then asked whether hydrogen
peroxide promotes degradation of the Bmi1 protein and, if so,
in a p38-dependent manner. Consistent with the recent report
(Kim et al., 2011), hydrogen peroxide promoted Bmi1 protein
degradation in a p38-dependent manner in the GICs (Figs. 4E
and F; Figs. S9C and D).Hydrogen peroxide activates FoxO3, an inducer of
differentiation of GICs, in a p38
MAPK-dependent manner
Thus far, we have shown that, whereas the ROS-p38 axis
mediates both loss of self-renewal and differentiation of
GICs induced by hydrogen peroxide, p38-mediated degrada-
tion of Bmi1 may be responsible for the loss of self-renewalbut not for the differentiation of GICs. Our results therefore
give rise to the idea that there exists another molecule(s)
aside from Bmi1 mediating the differentiation signal elicited
by hydrogen peroxide. Intriguingly, we have recently demon-
strated that, in contrast to leukemia-initiating cells of chronic
myeloid leukemia which require FoxO3 for their maintenance
(Naka et al., 2010), FoxO3 activation is rather required for the
differentiation but not for the loss of self-renewal of stem-like
GICs induced by hydrogen peroxide, which was confirmed also
in the experimental condition of this study (Figs. 5A and B;
Figs. S10A and B). We therefore hypothesized that FoxO3
could be the missing link between the ROS–p38 axis and
differentiation. To test this idea, we investigated the role of
ROS and p38 in hydrogen peroxide-induced activation of
FoxO3. As reported previously, FoxO3 is expressed predom-
inantly in the cytoplasm of untreated GICs, but hydrogen
peroxide treatment caused FoxO3 activation as evidenced
by its accumulation in the nucleus (Figs. 5C and D; Figs. S10C
and D). However, FoxO3 activation was almost completely
prevented when the GICs were treated with hydrogen
peroxide in the presence of NAC (Fig. 5C; Fig. S10C), SB203580
(Fig. 5D; Fig. S10D), or siRNAs against p38 (Fig. 5E), suggesting
that hydrogen peroxide activation of FoxO3 is dependent
on the increase in intracellular ROS and p38 activation.
Collectively, the data are in support of the idea that the
Figure 5 Hydrogen peroxide activates FoxO3, an inducer of GIC differentiation, in an intracellular ROS- and p38 MAPK-dependent
manner. (A, B) GS-Y03 cells transfected with the indicated siRNAs were treated, 10 h after transfection, with or without H2O2
(100 μM) for 6 days. The cells were then subjected to immunoblot analysis (A) or to sphere formation assays (B). The data represent
means ± SD from 3 independent experiments in (B). (C, D) GS-Y03 cells treated with or without H2O2 (100 μM) in the absence or
presence of NAC (10 mM) (C) or SB203580 (10 μM) (D) for 3 days were subjected to subcellular fractionation followed by immunoblot
analysis for FoxO3 as well as for α-tubulin (a cytoplasmic protein) and PARP (a nuclear protein). (E) GS-Y03 cells were transfected
with the indicated siRNAs. After 10 h, the transfected cells were treated with or without H2O2 (100 μM) for 6 days and then subjected
to subcellular fractionation followed by immunoblot analysis for FoxO3 as well as for α-tubulin (a cytoplasmic protein) and PARP
(a nuclear protein).
127ROS-p38 regulation of glioma-initiating cellshydrogen peroxide-elicited intracellular signals culminating
in the loss of self-renewal and differentiation of GICs are
transmitted through the ROS–p38 axis and then diverge to be
mediated by Bmi1 and FoxO3, respectively (see Discussion
section).p38-dependent promotion of GIC differentiation
induced by L-buthionine sulfoximine, an inhibitor
of GSH biosynthesis
Having shown that the ROS–p38 axis plays a pivotal role in
the loss of self-renewal and differentiation of GICs induced
by exposure to exogenous ROS (i.e., hydrogen peroxide
treatment), most likely through modulation of Bmi1 andFoxO3, we next wished to ask whether the ROS–p38 axis
could play a role in the control of GICs in the absence of
exogenously applied ROS. To this end, we treated GICs with
L-buthionine sulfoximine (BSO), an inhibitor of GSH biosyn-
thesis (Bailey, 1998; Boivin et al., 2011). Treatment of
GICs with BSO caused the accumulation of intracellular
ROS (Figs. 6A and B; Figs. S11A and B) as well as the
phosphorylation of p38 and ATF2 (Figs. 6C and E; Figs. S11C
and E). BSO also induced differentiation of the GICs, as
evidenced by decreased and increased expression of stem
cell and differentiation markers (Figs. 6D and E; Figs. S11D
and E), respectively. Importantly, all these changes caused
by BSO were prevented when the intracellular ROS were
depleted by NAC (Figs. 6C and D; Figs. S11C and D) or when
p38 activation was inhibited by SB203580 (Fig. 6E; Fig.
Figure 6 p38 MAPK-dependent promotion of GIC differentiation induced by L-buthionine sulfoximine (BSO), an inhibitor of GSH
biosynthesis. (A) GS-Y03 cells treated with the indicated concentrations of BSO for 30 min were stained with DCF-DA and analyzed by
flow cytometry. The graph shows the percentage of cells positive for DCF-DA. The data represent means ± SD from 3 independent
experiments. (B) GS-Y03 cells cultured in the presence or absence of NAC (10 mM) for 30 min were further treated with BSO (1 mM)
for 30 min. The cells were then stained with DCF-DA and subjected to fluorescence microscopy after nuclear staining with Hoechst
33342 (Hoechst). Identical visual fields are shown for each pair of DCF-DA and Hoechst staining. Scale bars, 100 μm. (C–E) GS-Y03
cells cultured in the absence or presence of NAC (10 mM) (C and D) or SB203580 (SB, 10 μM) (E) for 30 min were further treated with
or without BSO (1 mM) for 6 days. The cells were then subjected to immunoblot analyses of the indicated proteins.
128 A. Sato et al.S11E). Thus, these results suggest that GICs may undergo
ROS–p38 axis-dependent differentiation when the antioxi-
dant defense mechanism is inactivated.Pivotal role for ROS-dependent p38 MAPK activation
in oxidative stress-induced loss of tumor-initiating
capacity of GICs
Having demonstrated the role of the ROS–p38 axis in the
control of the differentiation process of GICs, we next wishedto ask whether ROS activation of p38 also plays a role in the
control of tumor-initiating capacity of GICs as well as of their
differentiation. As we have reported previously, treatment of
GICs with hydrogen peroxide before implantation significantly
extended survival of mice in the intracranial xenograft model
(Fig. 7A) (Sunayama et al., 2011).We then examined the effect
of the antioxidant NAC and p38 inhibitor SB203580 in the
xenograft analysis. Strikingly, whereas treatment of GICs with
either NAC or SB203580 alone before implantation had no
discernible effect on the survival of the mice (Fig. 7B),
co-treatment with NAC or SB203580 almost totally canceled
Figure 7 Pivotal role for ROS-dependent p38 MAPK activation
in hydrogen peroxide-induced loss of tumor-initiating capacity
of GICs. (A, B) GS-Y03 cells cultured in the absence or presence of
NAC (10 mM) or SB203580 (SB, 10 μM) for 30 min were further
treated with or without H2O2 (100 μM) as indicated in the figure
for 6 days, and the cells (1 × 104) were then implanted intracra-
nially into nude mice. Kaplan–Meier survival curves of the mice
(5 mice per group) are shown separately in (A) and (B), to avoid
overlap of neighboring curves. Note that the curves for the control
group (indicated by (−)) in (A) and (B) are identical. *P b 0.05.
n.s., not significant.
129ROS-p38 regulation of glioma-initiating cellsthe survival benefit of hydrogen peroxide treatment thatwould
have been conferred if the GICs had been treated with
hydrogen peroxide alone (Fig. 7A). Thus, the results suggest
that, while the basal levels of intracellular ROS and p38 activity
may not have a major impact on the tumor-initiating capacity
of GICs, ROS-dependent activation of p38 is essential for the
loss of tumor-initiating capacity caused by oxidative stress.GICs havemorepotent antioxidant defensemechanism
than their serum-differentiated counterparts
Our earlier observation that BSO induced p38-dependent
differentiation of GICs suggested that the intracellular ROS
level of GICs should be kept low by actively scavenging ROS
produced by the cells themselves to prevent premature p38
activation and maintain the undifferentiated state for self-
renewal. We therefore hypothesized that GICs may have a
higher capacity to remove intracellular ROS, in other words,
more potent antioxidant defense mechanism compared to
differentiated tumor cells. To test this idea, we used in this
study pairs of undifferentiated and serum-differentiated GICs
(Matsuda et al., 2012) and compared their capacity to resist
oxidative challenge. When GICs and their serum-differentiated
counterparts were treated with different concentrationsof hydrogen peroxide, the intracellular ROS levels were
consistently lower in undifferentiated cells than in serum-
differentiated cells in all three GICs examined (Figs. S12A
and B). Thus, the results are in support of the idea that GICs
may have a more potent antioxidant defense mechanism
compared to their differentiated counterparts, which could be
a reflection of the necessity of GICs to keep the intracellular
ROS level in check to maintain their stem-like state.Discussion
Despite the wealth of studies investigating the role of ROS in
cancer cell biology (Pan et al., 2009), surprisingly little is
known about its specific role in cancer stem cells (Kobayashi
and Suda, 2012; Shi et al., 2012). In particular, control of the
cellular fate of cancer stem cells, i.e., to remain in the stem
cell state and continue self-renewal or to undergo differen-
tiation into specific lineages, is one of the most important
issues to be addressed and elucidated in the field of cancer
stem cell biology. However, the role of ROS in the control
of this critical cellular decision process remains largely
unexplored (Kobayashi and Suda, 2012; Shi et al., 2012).
With respect to normal stem cells such as hematopoietic stem
cells and neural stem cells, there are a number of studies that
examined the role of ROS in their biology. However, most of
the studies are focused on the role of ROS in the control of
their proliferation and self-renewal, and few address the role
of ROS in the process of differentiation (Ito et al., 2004, 2006;
Kim andWong, 2009; Le Belle et al., 2011; Smith et al., 2000).
Furthermore, the results of the studies indicate that the role
of ROS in the control of stem cell self-renewal, for example,
may be context-dependent, lending support to both ideas that
ROS promote and inhibit self-renewal of stem cells (Ito
et al., 2004, 2006; Kim and Wong, 2009; Le Belle et al.,
2011; Smith et al., 2000; Yang et al., 2012). Thus, the role of
ROS in the control of self-renewal and differentiation of cancer
stem cells is not only unknown but is even unpredictable from
current literature, warranting and underscoring the necessity
of investigating their role in stem cells of each cancer type.
Here in this study, we examined the role of ROS in GICs
and demonstrated that intracellular ROS promote both the
loss of self-renewal and the differentiation of GICs, together
with the molecular mechanism involved therein. Strikingly, our
results suggested that “loss of self-renewal” and “differentia-
tion” are separable phases governed by distinct molecules that
are not necessarily coupled. We found, consistent with a
previous report (Abdouh et al., 2009), that Bmi1 plays a key role
in the maintenance of self-renewal capacity of GICs by showing
that knockdown of Bmi1 impairs sphere formation and stem cell
marker expression by GICs, but that Bmi1 knockdown alone is
not sufficient to induce their differentiation. On the other
hand, we have previously demonstrated that FoxO3 activation
is sufficient to drive GICs into differentiation (Sunayama et al.,
2011), and found in this study that FoxO3 knockdown does
prevent differentiation of GICs promoted by ROS. Nevertheless,
even in the absence of FoxO3 activation, GICs still underwent
ROS-dependent loss of self-renewal capacity (i.e., reduced
sphere formation and stem cell marker expression) yetwithout
differentiation marker expression. These findings bring to
light an “intermediate” cellular state (neither stem-like nor
differentiated) that stands in the middle of the process of
130 A. Sato et al.differentiation and also suggest that differentiation is not a
“default consequence” of loss of self-renewal. Importantly,
we successfully identified p38 as a key player that orchestrates
these two disparate phases. We have shown that p38 is
required for both ROS-induced Bmi1 degradation and FoxO3
activation, and consistent with its role as a master regulator of
Bmi1 and FoxO3, oxidative stress failed to promote loss of
self-renewal and differentiation of GICs when the activity of
p38 was blocked. The detailed mechanisms by which p38
promotes Bmi1 degradation and FoxO3 activation remain to be
determined and speculative, but Bmi1 phosphorylation by
p38-activated MAPKAP kinase 3 may play a role in Bmi1
degradation (Kim et al., 2011; Voncken et al., 2005), and
p38 itself has been shown to directly phosphorylate and
activate FoxO3 (Ho et al., 2012).
The pivotal role of the ROS–p38 axis in the control of the
tumor-initiating capacity of GICs was also demonstrated in
this study. We have previously shown that treatment with
hydrogen peroxide inhibits the tumor-initiating capacity of
GICs, suggesting that ROS may be involved in the control of
their tumor-initiating capacity (Sunayama et al., 2011).
Here, the results of this study indicate that the inhibitory
effect of hydrogen peroxide on the tumor-initiating capacity
of GICs is effectively canceled by concomitant treatment with
an antioxidant NAC or a p38 inhibitor SB203580, demonstrat-
ing that increase in intracellular ROS and p38 activation are
responsible for the loss of tumor-initiating capacity of GICs.
Regarding how the ROS–p38 axis controls the tumor-initiating
capacity of GICs, onemight assume that p38-dependent FoxO3
activation plays a key role, given our previous data indicating
that FoxO3 activation is sufficient to deprive GICs of their
tumor-initiating capacity (Sunayama et al., 2011). However, a
previous study demonstrated that Bmi1 knockdown is suffi-
cient to inhibit the tumor-initiating capacity of GICs (Abdouh
et al., 2009), which we also confirmed in our study (Fig. S14).
If we take both these observations into consideration, we
could safely speculate that the activation of the ROS–p38 axis
would ensure loss of tumor-initiating capacity of GICs in a
“redundant”manner, i.e., through both Bmi1 downregulation
and FoxO3 upregulation. Here, it may deserve noting that
Bmi1 knockdown, which did not induce differentiation of GICs
in vitro at least in our experimental condition, was sufficient
to inhibit their tumor-initiating capacity. The role of differen-
tiation per se in the control of tumor-initiating capacity of GICs
remains unknown, but it is imaginable that cells not committed
to differentiation may have a higher chance of reverting
to the stem-like condition, i.e., to tumor-initiating cells.
Whether differentiation plays a role in “stably maintaining”
the cellular state characterized by loss of tumor-initiating
capacity, therefore, may be among the issues to be addressed
in future studies.
We have demonstrated also in this study that inhibition
of the cellular antioxidant mechanism could promote
differentiation of GICs. We also observed that GICs have
an enhanced antioxidant mechanism compared to their
serum-differentiated counterparts. Based on these find-
ings, we speculate that GICs may need to actively maintain
their intracellular ROS levels below a threshold to prevent
loss of self-renewal and premature differentiation. Indeed,
cancer stem cells have been associated with lower levels of
intracellular ROS than non-stem cancer cells in human breast
cancers and in head and neck cancers (Diehn et al., 2009).Thus, it would also be interesting to speculate that the ROSlow
phenotype is a common property of cancer stem cells required
for the maintenance of their self-renewal capacity. However,
even if it is actually the case, we need to be reminded that this
does not necessarily imply that an increase in the intracellular
ROS level is the “physiological cue” for the loss of the stem-
like properties and tumor-initiating capacity of GICs. Indeed,
our data indicated that inhibition of the ROS–p38 axis alone
failed to have a discernible effect on and therefore was not
required for normal tumor growth. In contrast, our data at the
same time indicated that the activation of the ROS–p38 axis
has a significant inhibitory effect on tumor growth. Since the
intracellular ROS level is elaboratelymaintained low through a
network of antioxidant enzymes and nuclear factors that
control them (Zhang et al., 2010), interventions to perturb
either each enzyme or this network system as a whole would
therefore be of therapeutic benefit.
In conclusion, we have shown that ROS have a role in the
control of the stem-like state and differentiation of GICs. An
increase in intracellular ROS caused loss of self-renewal and
differentiation of GICs via p38-mediated degradation of Bmi1
and activation of FoxO3, respectively. Our results also suggest
that the ROS–p38 axis may be a novel therapeutic target
to curb the tumor-initiating capacity of GICs. Interventions
modulating the intracellular ROS level could therefore be a
potential therapeutic approach to prevent recurrence and
realize better clinical management of glioblastoma.Conflict of interest statement
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